Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | Hemodynamic Support Devices

A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...

Home September 12, 2019
Home
News | Cath Lab

September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major ...

Home September 10, 2019
Home
The cath lab staff UH Portage Medical Center.
Feature | Cath Lab | Anjan Gupta, M.D., FACC, FSCAI

Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute ST-segment elevation myocardial ...

Home September 09, 2019
Home
News | Stents Drug Eluting

September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...

Home September 05, 2019
Home
News | Heart Valve Technology

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...

Home September 05, 2019
Home
News | Cath Lab

September 3, 2019 — Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug ...

Home September 03, 2019
Home
News | Robotic Systems

September 3, 2019 — Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published by Th ...

Home September 03, 2019
Home
Technology | Vascular Access

September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven ...

Home September 03, 2019
Home
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home September 03, 2019
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices
Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor

August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the ...

Home August 28, 2019
Home
News | Left Atrial Appendage (LAA) Occluders

August 28, 2019 — AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home August 28, 2019
Home
News | Cath Lab

August 27, 2019 — Imagine there were a drug that you could take soon after a heart attack that could reduce damage by ...

Home August 27, 2019
Home
News | Peripheral Artery Disease (PAD)

August 27, 2019 — Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug ...

Home August 27, 2019
Home
Subscribe Now